
Erythropoietin Drugs Market Poised for Massive Growth, Projected to Hit $24.6 Billion by 2032 at 9.68% CAGR
The main factor compelling the expansion of the erythropoietin market is the rise in anemic conditions caused by chemotherapy, antiretroviral treatment (ART) US, NY, UNITED STATES, March 18, 2025 /EINPresswire.com/ -- In the evolving landscape …